Ahn C, Baek S
Front Pharmacol. 2025; 16:1522285.
PMID: 40051570
PMC: 11882530.
DOI: 10.3389/fphar.2025.1522285.
Benjamin A, Nayak S
Discov Nano. 2025; 20(1):18.
PMID: 39883285
PMC: 11782756.
DOI: 10.1186/s11671-024-04163-w.
Kennedy B, Noftall E, Dean C, Roth A, Clark K, Rowles D
Front Immunol. 2025; 15:1512543.
PMID: 39872527
PMC: 11769938.
DOI: 10.3389/fimmu.2024.1512543.
Rajan A, Laha S, Sahu N, Thorat N, Shankar B
Mater Today Bio. 2024; 29:101348.
PMID: 39669801
PMC: 11636219.
DOI: 10.1016/j.mtbio.2024.101348.
Omar H, Alkurdi Y, Fathima A, Alsharaeh E
Nanomaterials (Basel). 2024; 14(19).
PMID: 39404274
PMC: 11477580.
DOI: 10.3390/nano14191547.
Hyperthermia Intensifies α-Mangostin and Synthetic Xanthones' Antimalignancy Properties.
Rech J, Zelaszczyk D, Marona H, Gunia-Krzyzak A, Zmudzki P, Bednarek I
Int J Mol Sci. 2024; 25(16).
PMID: 39201559
PMC: 11354364.
DOI: 10.3390/ijms25168874.
Iron Oxide Nanoparticles: Parameters for Optimized Photoconversion Efficiency in Synergistic Cancer Treatment.
Grancharova T, Zagorchev P, Pilicheva B
J Funct Biomater. 2024; 15(8).
PMID: 39194645
PMC: 11355745.
DOI: 10.3390/jfb15080207.
The Role of Hyperthermic Intrathoracic Chemotherapy (HITHOC) in Thoracic Tumors.
Danuzzo F, Sibilia M, Vaquer S, Cara A, Cassina E, Libretti L
Cancers (Basel). 2024; 16(14).
PMID: 39061153
PMC: 11274823.
DOI: 10.3390/cancers16142513.
FeO and FeO Au-based Hyperthermia Reduces Expression of Proliferation Markers and in a Human Breast Cancer Cell Line.
Grammatikaki S, Bala V, Katifelis H, Lampropoulou D, Mukha I, Vityuk N
In Vivo. 2024; 38(4):1665-1670.
PMID: 38936909
PMC: 11215606.
DOI: 10.21873/invivo.13616.
Zwitterionic nanoparticles for thermally activated drug delivery in hyperthermia cancer treatment.
Colli C, Masi I, Jacchetti E, Santoni S, Sponchioni M, Colosimo B
Nanoscale. 2024; 16(26):12635-12649.
PMID: 38884523
PMC: 11223588.
DOI: 10.1039/d4nr00723a.
Titanium dioxide nanostructure-loaded Adriamycin surmounts resistance in breast cancer therapy: ABCA/P53/C-myc crosstalk.
Abdel-Megeed R, Abdel-Hamid A, Kadry M
Future Sci OA. 2024; 10(1):FSO979.
PMID: 38827789
PMC: 11140649.
DOI: 10.2144/fsoa-2023-0107.
Inhibiting AGS Cancer Cell Proliferation through the Combined Application of Aucklandiae Radix and Hyperthermia: Investigating the Roles of Heat Shock Proteins and Reactive Oxygen Species.
Ahn C, Ha I, Kim J, Ahn K, Park J, Baek S
Antioxidants (Basel). 2024; 13(5).
PMID: 38790669
PMC: 11118127.
DOI: 10.3390/antiox13050564.
The multifaceted benefits of passive heat therapies for extending the healthspan: A comprehensive review with a focus on Finnish sauna.
Laukkanen J, Kunutsor S
Temperature (Austin). 2024; 11(1):27-51.
PMID: 38577299
PMC: 10989710.
DOI: 10.1080/23328940.2023.2300623.
Tumor hyperthermia research progress and application prospect in tumoroids (Review).
Mao W, Li W, Hu X
Mol Clin Oncol. 2024; 20(4):31.
PMID: 38476334
PMC: 10928662.
DOI: 10.3892/mco.2024.2729.
Combination Treatment with Liposomal Doxorubicin and Inductive Moderate Hyperthermia for Sarcoma Saos-2 Cells.
Orel V, Diedkov A, Ostafiichuk V, Lykhova O, Kolesnyk D, Orel V
Pharmaceuticals (Basel). 2024; 17(1).
PMID: 38276006
PMC: 10819935.
DOI: 10.3390/ph17010133.
Enhancing Gastric Cancer Therapeutic Efficacy through Synergistic Cotreatment of Linderae Radix and Hyperthermia in AGS Cells.
Ahn C, Baek S
Biomedicines. 2023; 11(10).
PMID: 37893084
PMC: 10604735.
DOI: 10.3390/biomedicines11102710.
The Therapeutic Effects of MUC1-C shRNA@FeO Magnetic Nanoparticles in Alternating Magnetic Fields on Triple-Negative Breast Cancer.
Li Z, Guo T, Zhao S, Lin M
Int J Nanomedicine. 2023; 18:5651-5670.
PMID: 37822991
PMC: 10563812.
DOI: 10.2147/IJN.S426849.
Combination Therapy of Radiation and Hyperthermia, Focusing on the Synergistic Anti-Cancer Effects and Research Trends.
Kwon S, Jung S, Baek S
Antioxidants (Basel). 2023; 12(4).
PMID: 37107299
PMC: 10136118.
DOI: 10.3390/antiox12040924.
Mechanistic Insights on Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.
Huffman O, Chau D, Dinicu A, DeBernardo R, Reizes O
Cancers (Basel). 2023; 15(5).
PMID: 36900195
PMC: 10000881.
DOI: 10.3390/cancers15051402.
A Review of the Current Clinical Evidence for Loco-Regional Moderate Hyperthermia in the Adjunct Management of Cancers.
Chia B, Ho S, Tan H, Chua M, Tuan J
Cancers (Basel). 2023; 15(2).
PMID: 36672300
PMC: 9856725.
DOI: 10.3390/cancers15020346.